The presentation will focus on the use of receptor-mediated targeted drug delivery to deliver large molecules to the brain for Alzheimer's disease. Specifically, the presentation will cover ...
MyTACTIC: Afficacy and safety of atezolizumab (atezo) + chemotherapy (chemo) in patients (pts) with advanced unresectable/metastatic solid tumors with high tumor ...
This new article publication from Acta Pharmaceutica Sinica B, discusses a transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB ...
STOCKHOLM, Nov. 6, 2024 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ: BIOA B) (STOCKHOLM: BIOA B) has presented the design of its proprietary BrainTransporter (BT) platform at the 16th annual Protein & ...
Therapeutic antibodies have transformed patient outcomes across cancer, autoimmune disorders, and rare diseases, but this success has yet to translate to central nervous system (CNS) disorders. The ...
Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results, researchers are now watching individual molecules collide with cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results